In this brief review, we shall discuss recent important evidences of the potential clinical benefit of the incretin effect on cardiovascular system as well as the biological mechanisms, which underlie these effects
A systematic review found no clinical safety data beyond a very small case series, emphasizing that the safety profile for chronic use in humans remains uncharacterized
However, retained gastric content was more frequent, often necessitating cancellation or postponement of endoscopy
The GH-IGF-1 axis seems to play a role in certain cancers
Seiler A, Schneider M, Frster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rdmark O, Wurst W, et al